FNDC5 and myeloid sarcoma: Serum irisin was elevated in MS patients and EAE mice, whereas FNDC5 (fibronectin type III domain-containing protein 5)/irisin mRNA levels were decreased in both the spinal cord and brain, regardless of whether EAE was at the onset, peak, or chronic phase.